US Jury's Neurontin Ruling To Cost Pfizer Inc. $142 Million

Published: Mar 26, 2010

Philadelphia Inquirer -- Pfizer Inc. was found by a jury yesterday to have committed racketeering fraud in the marketing of its epilepsy drug Neurontin and must pay $142.1 million in damages.

Back to news